These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18406454)

  • 21. Cardiac mechano-electric feedback and electrical restitution in humans.
    Taggart P; Lab M
    Prog Biophys Mol Biol; 2008; 97(2-3):452-60. PubMed ID: 18407323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.
    Dobrev D; Nattel S
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):293-9. PubMed ID: 18791467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ionic currents and ventricular fibrillation dynamics].
    Moreno J; Warren M; Jalife J
    Rev Esp Cardiol; 2004 Jan; 57(1):69-79. PubMed ID: 14746720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
    Anderson ME
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):655-6. PubMed ID: 16836717
    [No Abstract]   [Full Text] [Related]  

  • 28. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation in heart failure: steady progress but still a long way to go.
    Stambler BS; Laurita KR
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):77-9. PubMed ID: 19808396
    [No Abstract]   [Full Text] [Related]  

  • 30. [The concise history of atrial fibrillation].
    Fazekas T
    Orvostort Kozl; 2007; 53(3-4):37-68. PubMed ID: 19069037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of potassium currents in cardiac arrhythmias.
    Ravens U; Cerbai E
    Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation.
    McBride BF
    J Clin Pharmacol; 2009 Mar; 49(3):258-67. PubMed ID: 19246727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adrenaline-induced autorhythmic activity in the isolated atrial myocardium of mitral stenosis patients and its suppression by etmozin and ethacizin (the diethylamino analog of etmozin)].
    Shkliar TF; Rozenshtraukh LV; Markhasin VS; Savichevskiĭ MS
    Biull Eksp Biol Med; 1984 Oct; 98(10):462-6. PubMed ID: 6388659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inward rectifier potassium currents as a target for atrial fibrillation therapy.
    Ehrlich JR
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):129-35. PubMed ID: 18670367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
    Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphology and function of the intrinsic cardiac nervous system].
    Schauerte P; Schimpf T; Mischke K; Zarse M; Schmid M; Plisiene J; Maurath P; Kelm M; Pauza DH
    Herz; 2006 Apr; 31(2):96-100. PubMed ID: 16738830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conduction abnormalities and anaesthesia.
    Santambrogio L; Braschi A
    Curr Opin Anaesthesiol; 2007 Jun; 20(3):269-73. PubMed ID: 17479033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putative druggable targets for selective enhancement of cardiac conduction.
    Gomes J; Lambiase PD
    Curr Opin Pharmacol; 2009 Apr; 9(2):154-9. PubMed ID: 19109070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone as paradigm for developing new drugs for atrial fibrillation.
    Singh BN
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):300-5. PubMed ID: 18841075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
    Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
    Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.